Global Bartholin’s Cyst Market, By Symptoms (Painful Lump Near the Vaginal Opening, Discomfort in Walking/Sitting, Pain During Intercourse, Fever), Diagnosis (Pelvic Examination, Biopsy), Treatment (Sitz Bath, Surgical Drainage, Antibiotics, Marsupialization), End-User (Hospitals, Ambulatory Surgical Centers, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Industry Trends and Forecast to 2030.
Bartholin’s Cyst Market Analysis and Size
The rapid increase in the cases of Bartholin’s cyst is expected to accelerate the market growth in the forecast period. Likewise, the rise in the women population and the presence of well-developed healthcare infrastructure are also predictable to enhance the Bartholin’s cyst market growth. Furthermore, the rise in the percentage of people belonging to sexually active age group, rise in the awareness about the disease and its treatment among women and the increase in the research and development are also projected to drive the market growth rate. In addition, the presence of advanced healthcare facilities, rise in the R&D initiatives and favourable government support are likely to create various new opportunities that will impact this Bartholin’s cyst market growth in the forecast period.
Data Bridge Market Research analyses that the bartholin’s cyst market which was USD 577.15 million in 2022, would rocket up to USD 912.9 Million by 2030, and is expected to undergo a CAGR of 5.9% during the forecast period. This indicates that the market value. “Painful Lump near the Vaginal Opening” dominates the application segment of the bartholin’s cyst market owing to the increasing incidence of bartholin's cysts. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Bartholin’s Cyst Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Symptoms (Painful Lump Near the Vaginal Opening, Discomfort in Walking/Sitting, Pain During Intercourse, Fever), Diagnosis (Pelvic Examination, Biopsy), Treatment (Sitz Bath, Surgical Drainage, Antibiotics, Marsupialization), End-User (Hospitals, Ambulatory Surgical Centers, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
|
|
Countries Covered
|
U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E., Kuwait, Israel, Egypt, Rest of the Middle East and Africa
|
|
Market Players Covered
|
Johnson & Johnson Services, Inc. (U.S.), Sanofi (France), Bayer AG (Germany), Abbott (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Melinta Therapeutics LLC (U.S.), Merck & Co., Inc. (U.S.), Allergan (Ireland), AbbVie Inc. (U.S.), Pfizer Inc. (U.S.), Novartis AG (Switzerland), Mylan N.V (U.S.), Lupin (India), Amneal Pharmaceuticals LLC (U.S.), Zydus Cadila (India), Bausch Health Companies Inc. (Canada), Teva Pharmaceutical Industries Ltd (Israel), KYORIN Holdings, Inc. (Japan), MerLion Pharmaceuticals GmbH (Germany), Wockhardt (India
|
|
Market Opportunities
|
|
Market Definition
Bartholin's cyst is a type of a noncancerous lump which usually develops due to a blockage in the bartholin’s glands. The bartholin's glands are present between the vagina and the vulva and are not generally visible to the naked eye. They produce a fluid which helps to reduce friction during intercourse.
Bartholin’s Cyst Market Dynamics
Drivers
- Increasing Incidence
The prevalence of bartholin's cysts and abscesses is on the rise, partly due to increased awareness and improved diagnosis. This drives the demand for treatment options and medical interventions.
- Advancements in Medical Technology
Technological advancements in diagnostic tools and treatment procedures, such as minimally invasive surgical techniques, have improved patient outcomes and expanded treatment options.
- Rising Healthcare Expenditure
The growing healthcare expenditure worldwide allows patients to access a broader range of healthcare services, including the treatment of bartholin's cysts.
- Increasing Awareness
Greater awareness among both patients and healthcare professionals about Bartholin's cysts and their management has led to early diagnosis and timely treatment.
Opportunities
- Minimally Invasive Techniques
Further advancement in minimally invasive surgical techniques can enhance patient comfort and reduce recovery times.
- Telemedicine and Remote Monitoring
Telemedicine and remote monitoring solutions can improve access to care and ongoing management of bartholin's cysts, especially in underserved or remote areas.
Restraints/Challenges
- Limited Treatment Options
While minimally invasive procedures have improved outcomes, there is still a need for more effective and less invasive treatment options. This limitation can be a challenge for patients and healthcare providers.
- Socioeconomic Factors
Access to healthcare services and treatment may be limited in certain regions or among underserved populations, affecting their ability to manage bartholin's cysts effectively.
- Complications and Recurrence
Some cases of bartholin's cysts may lead to complications or recurrence after treatment, requiring additional medical attention.
This bartholin’s cyst market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the bartholin’s cyst market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Recent Developments
- In April 2019 Neoscope 2020 launched a new Neoscope Video Processing Module (VPU 5) with Light Intensity Control for use with commercial HD video monitors, and a Neoscope Video Link Module (NVL) for use with commercial tablet and laptop computers. Both the Model NVL and the Model VPU 5 are fully compatible with the Family of Single-Use Digital Endoscope Products, which includes Single-Use Rigid/Flexible Video Cystoscopes, Flexible/Semi-Rigid Ureteroscopes, and the Family of Nephroscopes for the Treatment of Urological Disorders
- In March 2021, Lucintel is delighted to announce UroViu Corporation's Cystoscopy Platform as the winner of the "2021 Product Innovation Award in the Single-Use Endoscopy Market." Lucintel chose UroViu Corporation for this award because of its novel, one-of-a-kind, single-use, disposable, and portable cystoscopy platform, which enables physicians to undertake interventional and predictive urologic methods in any room, at any time, without the need for reprocessing or peripherals.
Global Bartholin’s Cyst Market Scope
Bartholin’s cyst market is segmented on the basis of symptoms, diagnosis, treatment, end-user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Symptoms
- Painful Lump Near the Vaginal Opening
- Discomfort in Walking/Sitting
- Pain During Intercourse
- Fever
Diagnosis
- Pelvic Examination
- Biopsy
Treatment
- Sitz Bath
- Surgical Drainage
- Antibiotics and Marsupialization
End-User
- Hospitals
- Ambulatory Surgical Centers
- Others
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Bartholin’s Cyst Market Regional Analysis/Insights
Bartholin’s cyst market is analyzed and market size information is provided by country by symptoms, diagnosis, treatment, end-user and distribution channel as referenced above.
The countries covered in the bartholin’s cyst market report are the U.S., Canada, and Mexico in North America, Peru, Brazil, Argentina, and the Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E., Kuwait, Israel, Egypt, Rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA)
North America leads the bartholin’s cyst market due to the high prevalence of the disorder along with the presence of advanced healthcare facilities. Asia-Pacific is projected to observe significant amount of growth of the bartholin’s cyst market increase in the population and rise in awareness.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The bartholin’s cyst market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for bartholin’s cyst market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the bartholin’s cyst market. The data is available for historic period 2015 to 2020.
Competitive Landscape and Bartholin’s Cyst Market Share Analysis
The bartholin’s cyst market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company’s focus related to bartholin’s cyst market.
Some of the major players operating in the bartholin’s cyst market are:
- Johnson & Johnson Services, Inc. (U.S.)
- Sanofi (France)
- Bayer AG (Germany)
- Abbott (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Melinta Therapeutics LLC (U.S.)
- Merck & Co., Inc. (U.S.)
- Allergan (Ireland)
- AbbVie Inc. (U.S.)
- Pfizer Inc. (U.S.)
- Novartis AG (Switzerland)
- Mylan N.V (U.S.)
- Lupin (India)
- Amneal Pharmaceuticals LLC (U.S.)
- Zydus Cadila (India)
- Bausch Health Companies Inc. (Canada)
- Teva Pharmaceutical Industries Ltd (Israel)
- KYORIN Holdings, Inc. (Japan)
- MerLion Pharmaceuticals GmbH (Germany)
- Wockhardt (India)
SKU-